← Leaderboards
Harriet De Wit
University Of Chicago
$19,929,985
Attributed
$22,458,049
Total exposure
44
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$22,458,049 · 44
By mechanism
R01$17,731,869 · 4
T32$2,080,575 · 1
R21$1,685,636 · 4
M01$723,870 · 32
R03$226,099 · 2
R13$10,000 · 1
Top collaborators
- Kinh Luan Phan5 shared
- Xiaoxi Zhuang5 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Andrea C King$19,745,933
- Francis J McMahon$609,914
- Avery Tung$594,405
- Jean Decety$4,953,982
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchPharmaceutical PreparationsPreferenceBehavioral /Social Science Research TagResponsePsychopharmacologyBehavioralDextroamphetamineDrug UsageBaseAcuteDrug AbuseSourceBehaviorAmphetaminesIndividual DifferencesMediatingProceduresAlcoholsInnovationLinkBrainStimulus
Grant awards (122)
Determinants of Drug Preference in Humans$428,682
R01 · FY2024 · DA · contact PI
European Behavioral Pharmacology Society (EPBS) workshop on Novel Pharmacotherapies to Treat Substance Use Disorders: From Basic Science to Societal Implications$10,000
R13 · FY2024 · DA · contact PI
Determinants of Drug Preference in Humans$490,757
R01 · FY2023 · DA · contact PI
Determinants of Drug Preference in Humans$490,757
R01 · FY2022 · DA · contact PI
Determinants of Drug Preference in Humans$495,164
R01 · FY2021 · DA · contact PI
Integrative Training in the Neurobiology of Addictive Behaviors$438,826
T32 · FY2021 · DA · contact PI
Determinants of Drug Preference in Humans$439,775
R01 · FY2020 · DA · contact PI
Integrative Training in the Neurobiology of Addictive Behaviors$432,515
T32 · FY2020 · DA · contact PI
Determinants of Drug Preference in Humans$568,040
R01 · FY2019 · DA · contact PI
Integrative Training in the Neurobiology of Addictive Behaviors$414,898
T32 · FY2019 · DA · contact PI
Determinants of Drug Preference in Humans$600,996
R01 · FY2018 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans$420,297
R01 · FY2018 · DA · contact PI
Integrative Training in the Neurobiology of Addictive Behaviors$402,192
T32 · FY2018 · DA · contact PI
Determinants of Drug Preference in Humans$604,530
R01 · FY2017 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01$438,488
R01 · FY2017 · DA · contact PI
Integrative Training in the Neurobiology of Addictive Behaviors$392,144
T32 · FY2017 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01$97,529
R01 · FY2017 · DA · contact PI
Determinants of Drug Preference in Humans$598,148
R01 · FY2016 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01$434,103
R01 · FY2016 · DA · contact PI
Inhibitory Control and Drug Reward in Humans$195,525
R21 · FY2016 · DA · contact PI
Determinants of Drug Preference in Humans$603,839
R01 · FY2015 · DA · contact PI
The genetic basis of impulsive behavior in humans$494,333
R01 · FY2015 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01$442,294
R01 · FY2015 · DA · contact PI
Inhibitory Control and Drug Reward in Humans$237,000
R21 · FY2015 · DA · contact PI
The genetic basis of impulsive behavior in humans$459,611
R01 · FY2014 · DA · contact PI
Acquisition and persistence of drug cue conditioning in humans - Resubmission 01$438,715
R01 · FY2014 · DA · contact PI
Determinants of Drug Preference in Humans$425,651
R01 · FY2014 · DA · contact PI
The genetic basis of impulsive behavior in humans$44,240
R01 · FY2014 · DA · contact PI
The genetic basis of impulsive behavior in humans$442,665
R01 · FY2013 · DA · contact PI
Determinants of Drug Preference in Humans$392,257
R01 · FY2013 · DA · contact PI
Memory effects of stimulant drugs in humans$182,039
R21 · FY2013 · DA · contact PI
Determinants of Drug Preference in Humans--Administrative Supplement$157,840
R01 · FY2013 · DA · contact PI
The genetic basis of impulsive behavior in humans$467,166
R01 · FY2012 · DA · contact PI
Determinants of Drug Preference in Humans$411,458
R01 · FY2012 · DA · contact PI
Memory effects of stimulant drugs in humans$228,624
R21 · FY2012 · DA · contact PI
The genetic basis of impulsive behavior in humans$473,588
R01 · FY2011 · DA · contact PI
Determinants of Drug Preference in Humans$411,300
R01 · FY2011 · DA · contact PI
Is Ecstasy an Empathogen? Effects of MDMA on Social and Emotional Processing$231,660
R21 · FY2010 · DA · contact PI
Determinants of Drug Preference in Humans$426,442
R01 · FY2009 · DA · contact PI
Drug Abuse and Impulsivity: Human Laboratory Models$318,836
R01 · FY2009 · DA · contact PI
Is Ecstasy an Empathogen? Effects of MDMA on Social and Emotional Processing$192,500
R21 · FY2009 · DA · contact PI
Determinants of Drug Preference in Humans$382,009
R01 · FY2008 · DA · contact PI
Drug Abuse and Impulsivity: Human Laboratory Models$318,836
R01 · FY2008 · DA · contact PI
Craving During Smoking Abstinence: Does it Abate or Incubate?$188,038
R21 · FY2008 · DA · contact PI
Determinants of Drug Preference in Humans$397,966
R01 · FY2007 · DA · contact PI
Drug Abuse and Impulsivity: Human Laboratory Models$325,344
R01 · FY2007 · DA · contact PI
Craving During Smoking Abstinence: Does it Abate or Incubate?$230,250
R21 · FY2007 · DA · contact PI
GENETIC VARIATION IN DRUG RESPONSE$14,037
M01 · FY2007 · RR · contact PI
DETERMINANTS OF DRUG PREFERENCE STUDY 1$12,073
M01 · FY2007 · RR · contact PI
DRUG RESPONSES AND AROUSAL$10,950
M01 · FY2007 · RR · contact PI
EFFECTS OF SLEEP DEPRIVATION ON PERFORMANCE$6,738
M01 · FY2007 · RR · contact PI
SMOKING AND AROUSAL$3,089
M01 · FY2007 · RR · contact PI
ALERTNESS AND SMOKING$2,807
M01 · FY2007 · RR · contact PI
DRUG RESPONSES AND AROUSAL II$1,966
M01 · FY2007 · RR · contact PI
Determinants of Drug Preference in Humans$408,747
R01 · FY2006 · DA · contact PI
Drug Abuse and Impulsivity: Human Laboratory Models$335,061
R01 · FY2006 · DA · contact PI
DETERMINANTS OF DRUG PREFERENCE STUDY 1$217,422
M01 · FY2006 · RR · contact PI
EFFECTS OF SLEEP DEPRIVATION ON PERFORMANCE$75,747
M01 · FY2006 · RR · contact PI
GENETIC DETERMINANTS OF BEHAVIOR$54,006
M01 · FY2006 · RR · contact PI
GENETIC VARIATION IN DRUG RESPONSE$24,548
M01 · FY2006 · RR · contact PI
Determinants of Drug Preference in Humans$18,576
R01 · FY2006 · DA · contact PI
STRESS AND DRUG RESPONSES$7,716
M01 · FY2006 · RR · contact PI
GENETIC VARIATION IN ACUTE DRUG EFFECTS$701
M01 · FY2006 · RR · contact PI
DRUG RESPONSES AND AROUSAL$701
M01 · FY2006 · RR · contact PI
Determinants of Drug Preference in Humans$448,771
R01 · FY2005 · DA
Drug Abuse and Impulsivity: Human Laboratory Models$343,125
R01 · FY2005 · DA
DETERMINANTS OF DRUG PREFERENCE STUDY 1$74,510
M01 · FY2005 · RR
GENETIC VARIATION IN ACUTE DRUG EFFECTS$29,804
M01 · FY2005 · RR
Drug Abuse and Impulsivity: Human Laboratory Models$21,669
R01 · FY2005 · DA
STRESS AND DRUG RESPONSES$15,647
M01 · FY2005 · RR
GENETIC DETERMINANTS OF BEHAVIOR$4,471
M01 · FY2005 · RR
BLOOD LEVELS OF CANNABINOIDS$1,491
M01 · FY2005 · RR
GENETIC VARIATION IN DRUG RESPONSE$744
M01 · FY2005 · RR
Determinants of Drug Preference in Humans$404,040
R01 · FY2004 · DA
DRUG ABUSE AND IMPULSIVITY: HUMAN LABORATORY MODELS$171,619
R01 · FY2004 · DA
Genetic Variation in Acute Drug Effects$53,976
M01 · FY2004 · RR
Blood Levels of Cannabinoids$12,389
M01 · FY2004 · RR
DRUG ABUSE AND IMPULSIVITY: HUMAN LABORATORY MODELS$174,491
R01 · FY2003 · DA
Nicotinic Involvement &Consumption of Alcohol in Humans$76,250
R03 · FY2003 · AA
DETERMINANTS OF DRUG PREFERENCE$353,653
R01 · FY2002 · DA
DRUG ABUSE AND IMPULSIVITY: HUMAN LABORATORY MODELS$173,439
R01 · FY2002 · DA
Nicotinic Involvement &Consumption of Alcohol in Humans$76,250
R03 · FY2002 · AA
DETERMINANTS OF DRUG PREFERENCE$37,058
R01 · FY2002 · DA
HUMAN SMOKING STUDY 1A$0
M01 · FY2002 · RR
DRUGS AND PLASMA ALLOPREGNANOLONE LEVELS IN MEN &WOMEN$0
M01 · FY2002 · RR
SEROTONIN, IMPULSIVITY AND TYPE II ALCOHOLISM$0
M01 · FY2002 · RR
DETERMINANTS OF DRUG PREFERENCE IN HUMANS$0
M01 · FY2002 · RR
ESTROGEN IN POSTMENOPAUSAL WOMEN: DRUG PREFERENCE$0
M01 · FY2002 · RR
ETHANOL PREFERENCE ACROSS MENSTRUAL CYCLE$0
M01 · FY2002 · RR
PHARMACOLOGIC STUDIES OF MARIJUANA &DELTA 9 THC IN HUMANS$0
M01 · FY2002 · RR
EFFECTS OF PROGESTERONE IN POSTMENOPAUSAL AND NORMALLY-CYCLING WOMEN$0
M01 · FY2002 · RR
RESPONSE TO ACUTE GLUCOCORTICOID ADMINISTRATION$0
M01 · FY2002 · RR
EFFECTS OF 17-BETA-ESTRADIOL ON RESPONSE TO AMPHETAMINE$0
M01 · FY2002 · RR
EFFECTS OF MENSTRUAL CYCLE ON RESPONSE TO AMPHETAMINE$0
M01 · FY2002 · RR
DETERMINANTS OF DRUG PREFERENCE$308,828
R01 · FY2001 · DA
DRUG ABUSE AND IMPULSIVITY: HUMAN LABORATORY MODELS$160,095
R01 · FY2001 · DA
DETERMINANTS OF DRUG PREFERENCE$285,293
R01 · FY2000 · DA
DRUG ABUSE AND IMPULSIVITY: HUMAN LABORATORY MODELS$145,748
R01 · FY2000 · DA
BLOCKADE OF METHAMPHETAMINE SUBJECTIVE EFFECTS IN HUMANS$73,599
R03 · FY2000 · DA
ETHANOL PREFERENCE ACROSS MENSTRUAL CYCLE$32,779
M01 · FY2000 · RR
PHARMACOLOGIC STUDIES OF MARIJUANA &DELTA 9 THC IN HUMANS$32,779
M01 · FY2000 · RR
CHANGES IN APPETITE &GLOBAL HUNGER FOLLOWING ADMINISTRATION OF DRONABINOL$32,779
M01 · FY2000 · RR
DETERMINANTS OF DRUG PREFERENCE IN HUMANS$0
M01 · FY2000 · RR
ESTROGEN IN POSTMENOPAUSAL WOMEN: DRUG PREFERENCE$0
M01 · FY2000 · RR
ESTROGEN IN POSTMENOPAUSAL WOMEN: DRUG PREFERENCE$0
M01 · FY2000 · RR
ETHANOL PREFERENCE ACROSS MENSTRUAL CYCLE$0
M01 · FY2000 · RR
EFFECTS OF MENSTRUAL CYCLE ON RESPONSE TO AMPHETAMINE$0
M01 · FY2000 · RR
PHARMACOLOGIC STUDIES OF MARIJUANA &DELTA 9 THC IN HUMANS$0
M01 · FY2000 · RR
EFFECTS OF PROGESTERONE IN POSTMENOPAUSAL AND NORMALLY-CYCLING WOMEN$0
M01 · FY2000 · RR
EFFECTS OF PROGESTERONE IN POSTMENOPAUSAL AND NORMALLY-CYCLING WOMEN$0
M01 · FY2000 · RR
RESPONSE TO ACUTE GLUCOCORTICOID ADMINISTRATION$0
M01 · FY2000 · RR
RESPONSE TO ACUTE GLUCOCORTICOID ADMINISTRATION$0
M01 · FY2000 · RR
EFFECTS OF 17-BETA-ESTRADIOL ON RESPONSE TO AMPHETAMINE$0
M01 · FY2000 · RR
EFFECTS OF MENSTRUAL CYCLE ON RESPONSE TO AMPHETAMINE$0
M01 · FY2000 · RR
EFFECTS OF 17-BETA-ESTRADIOL ON RESPONSE TO AMPHETAMINE$0
M01 · FY2000 · RR
HUMAN SMOKING STUDY 1A$0
M01 · FY2000 · RR
HUMAN SMOKING STUDY 1A$0
M01 · FY2000 · RR
DRUGS AND PLASMA ALLOPREGNANOLONE LEVELS IN MEN &WOMEN$0
M01 · FY2000 · RR
DRUGS AND PLASMA ALLOPREGNANOLONE LEVELS IN MEN &WOMEN$0
M01 · FY2000 · RR
SEROTONIN, IMPULSIVITY AND TYPE II ALCOHOLISM$0
M01 · FY2000 · RR
SEROTONIN, IMPULSIVITY AND TYPE II ALCOHOLISM$0
M01 · FY2000 · RR
DETERMINANTS OF DRUG PREFERENCE IN HUMANS$0
M01 · FY2000 · RR